Комплементарные методы лечения детского церебрального паралича
Л. А. Пак
ФГБУ «Центральная клиническая больница с поликлиникой» УД Президента РФ, Москва,
О. Ю. Браун
А. П. Фисенко
А. М. Орбу
К. В. Чибисова
Л. А. Романова
Н. В. Вехова
PDF

Ключевые слова

детский церебральный паралич
лечение
альтернативная терапия
комплементарная терапия

Как цитировать

Пак, Л. А., Браун, О. Ю., Фисенко, А. П., Орбу, А. М., Чибисова, К. В., Романова, Л. А., & Вехова, Н. В. (2018). Комплементарные методы лечения детского церебрального паралича. КРЕМЛЕВСКАЯ МЕДИЦИНА<br><i>клинический вестник</I&gt;, (3), 80-85. извлечено от http://kremlin-medicine.ru/index.php/km/article/view/1289
PDF

Аннотация

В обзоре литературы рассматриваются такие методы комплементарного лечения детского церебрального паралича (ДЦП), представленные в отечественной и зарубежной литературе, как модифицированная терапия движением, индуцированным ограничением (MCIMT), терапия стволовыми клетками, система биологически обратной связи, а также некоторые другие комплементарные/паллиативные подходы к коррекции клинических проявлений различных форм ДЦП. Описанные методы практикуются в лечении детского церебрального паралича у детей и подростков в различных странах мира.
PDF

Литература

1. Gordon A.M., Charles J., Wolf S.L. Methods of constraint- induced movement therapy for children with hemiplegic cerebral palsy: development of a child-friendly intervention for improving upper-extremity function. Arch. Phys. Med. Rehabil. 2005; 86(4): 837-844.
2. Eliasson A.C., Krumlinde-Sundholm L., Shaw K., Wang C. Effects of constraint-induced movement therapy in young children with hemiplegic cerebral palsy: an adapted model. Dev. Med. Child. Neurol. 2005; 47(4): 266-275.
3. Naylor C.E., Bower E. Modified constraint-induced movement therapy for young children with hemiplegic cerebral palsy: a pilot study. Dev. Med. Child. Neurol. 2005; 47(6): 365- 369.
4. Charles J.R., Wolf S.L., Schneider J.A., Gordon A.M. Efficacy of a child-friendly form of constraint-induced movement therapy in hemiplegic cerebral palsy: a randomized control trial. Dev. Med. Child. Neurol. 2006; 48(8): 635-642.
5. Sutcliffe T.L., Gaetz W.C., Logan W.J. et al. Cortical reorganization after modified constraint-induced movement therapy in pediatric hemiplegic cerebral palsy. J. Child. Neurol. 2007; 22(11): 1281-1287.
6. Hoare B., Imms C., Carey L., Wasiak J. Constraintinduced movement therapy in the treatment of the upper limb in children with hemiplegic cerebral palsy: a Cochrane systematic review. Clin. Rehabil. 2007; 21(8): 675-685.
7. Hoare B.J., Wasiak J., Imms C., Carey L. Constraintinduced movement therapy in the treatment of the upper limb in children with hemiplegic cerebral palsy. Cochrane Database Syst. Rev. 2007; (2): CD004149.
8. Hoare B.J., Imms C., Rawicki H.B., Carey L. Modified constraint-induced movement therapy or bimanual occupational therapy following injection of botulinum toxin-A to improve bimanual performance in young children with hemiplegic cerebral palsy: a randomised controlled trial methods paper. BMC Neurol. 2010; 10: 58.
9. Hoare B., Imms C., Villanueva E. et al. Intensive therapy following upper limb botulinum toxin A injection in young children with unilateral cerebral palsy: a randomized trial. Dev. Med. Child. Neurol. 2013; 55(3): 238-247.
10. Cope S.M., Forst H.C., Bibis D., Liu X.C. Modified constraint-induced movement therapy for a 12-month-old child with hemiplegia: a case report. Am. J. Occup. Ther. 2008; 62(4): 430-437.
11. Wallen M., Ziviani J., Herbert R. et al. Modified constraint- induced therapy for children with hemiplegic cerebral palsy: a feasibility study. Dev. Neurorehabil. 2008; 11(2): 124- 133.
12. Smania N., Aglioti S.M., Cosentino A. et al. A modified constraint-induced movement therapy (CIT) program improves paretic arm use and function in children with cerebral palsy. Eur. J. Phys. Rehabil. Med. 2009; 45(4): 493-500.
13. Park E.S., Rha D.W., Lee J.D. et al. The short-term effects of combined modified constraint-induced movement therapy and botulinum toxin injection for children with spastic hemiplegic cerebral palsy. Neuropediatrics. 2009; 40(6): 269-274.
14. Coker P., Karakostas T., Dodds C., Hsiang S. Gait characteristics of children with hemiplegic cerebral palsy before and after modified constraint-induced movement therapy. Disabil Rehabil. 2010; 32(5): 402-408.
15. Aarts P.B., Jongerius P.H., Geerdink Y.A. et al. Effectiveness of modified constraint-induced movement therapy in children with unilateral spastic cerebral palsy: a randomized controlled trial. Neurorehabil Neural. Repair. 2010; 24(6): 509-518.
16. Aarts P.B., Jongerius P.H., Geerdink Y.A. et al. Modified Constraint-Induced Movement Therapy combined with Bimanual Training (mCIMT-BiT) in children with unilateral spastic cerebral palsy: how are improvements in arm-hand use established? Res. Dev. Disabil. 2011; 32(1): 271-279.
17. Aarts P.B., van Hartingsveldt M., Anderson P.G. et al. The Pirate group intervention protocol: description and a case report of a modified constraint-induced movement therapy combined with bimanual training for young children with unilateral spastic cerebral palsy. Occup. Ther. Int. 2012; 19(2): 76-87.
18. Choudhary A., Gulati S., Kabra M. et al. Efficacy of modified constraint induced movement therapy in improving upper limb function in children with hemiplegic cerebral palsy: a randomized controlled trial. Brain Dev. 2013; 35(9): 870-876. doi: pii: S0387-7604(12)00277-X. 10.1016/j.braindev. 2012.11.001.
19. Rostami H.R., Malamiri R.A. Effect of treatment environment on modified constraint-induced movement therapy results in children with spastic hemiplegic cerebral palsy: a randomized controlled trial. Disabil. Rehabil. 2012; 34(1): 40-44.
20. Deppe W., Thuemmler K., Fleischer J. et al. Modified constraint-induced movement therapy versus intensive bimanual training for children with hemiplegia – a randomized controlled trial. Clin. Rehabil. 2013; 27(10): 909-920.
21. Geerdink Y., Aarts P., Geurts A.C. Motor learning curve and long-term effectiveness of modified constraint-induced movement therapy in children with unilateral cerebral palsy: a randomized controlled trial. Res. Dev. Disabil. 2013; 34(3): 923-931.
22. DeLuca S.C., Echols K., Law C.R., Ramey S.L. Intensive pediatric constraint-induced therapy for children with cerebral palsy: randomized, controlled, crossover trial. J. Child. Neurol. 2006; 21(11): 931-938.
23. Hsin Y.J., Chen F.C., Lin K.C. et al. Efficacy of constraint- induced therapy on functional performance and healthrelated quality of life for children with cerebral palsy: a randomized controlled trial. J. Child. Neurol. 2012; 27(8): 992-999.
24. DeLuca S.C., Trucks M.R., Wallace D.A., Ramey S.L. Practice-based evidence from a clinical cohort that received pediatric constraint-induced therapy. J. Pediatr. Rehabil. Med. 2017; 10(1): 37-46. doi: 10.3233/PRM-170409.
25. Bartley J., Carroll J.E. Stem cell therapy for cerebral palsy. Expert. Opin. Biol. Ther. 2003; 3(4): 541-549.
26. Селедцов В.И., Кафанова М.Ю., Рабинович С.С., Повещенко О.В., Кащенко Э.А., Фельде М.А., Самарин Д.М., Селедцова Г.В., Козлов В.А. Клеточная терапия детского церебрального паралича. Клеточные технологии в биологии и медицине. 2005; 2: 84-88.
27. Seledtsov V.I., Kafanova M.Y., Rabinovich S.S. et al. Cell therapy of cerebral palsy. Bull. Exp. Biol. Med. 2005; 139(4): 499-503.
28. Goldman S.A., Schanz S., Windrem M.S. Stem cellbased strategies for treating pediatric disorders of myelin. Hum. Mol. Genet. 2008; (R1): R76-83.
29. Mehta T., Feroz A., Thakkar U. et al. Subarachnoid placement of stem cells in neurological disorders. Transplant. Proc. 2008; 40(4): 1145-1147.
30. Harris D.T. Cord blood stem cells: a review of potential neurological applications. Stem. Cell. Rev. 2008; 4(4): 269-274.
31. Harris D.T. Non-haematological uses of cord blood stem cells. Br. J. Haemat. 2009; 147(2): 177-184. 32. Ul Hassan A., Hassan G., Rasool Z. Role of stem cells in treatment of neurological disorder. Int. J. Health. Sci. (Qassim). 2009; 3(2): 227-233.
33. Patoine B. NerveCenter: media focus on ‘miracle cure’ for cerebral palsy pits science vs. hype. Ann. Neurol. 2009; 66(4): A9-11.
34. Patoine B. NerveCenter: Stem cells surge forward to clinical trials, but fears remain. Ann. Neurol. 2009; 65(5): A9- A11.
35. Mankikar S.D. Stem cells: a new paradigm in medical therapeutics. J. Long. Term. Eff. Med. Implants. 2010; 20(3): 219-250.
36. Bell E., Wallace T., Chouinard I. et al. Responding to requests of families for unproven interventions in neurodevelopmental disorders: hyperbaric oxygen “treatment” and stem cell “therapy” in cerebral palsy. Dev. Disabil. Res. Rev. 2011; 17(1): 19-26.
37. Carroll J.E., Mays R.W. Update on stem cell therapy for cerebral palsy. Expert. Opin. Biol. Ther. 2011; 11(4): 463-471.
38. Bennet L., Tan S., Van den Heuij L. et al. Cell therapy for neonatal hypoxia-ischemia and cerebral palsy. Ann. Neurol. 2012; 71(5): 589-600.
39. Li M., Yu A., Zhang F. et al. Treatment of one case of cerebral palsy combined with posterior visual pathway injury using autologous bone marrow mesenchymal stem cells. J. Transl. Med. 2012; 10: 100. 40. Purandare C., Shitole D.G., Belle V. et al. Therapeutic potential of autologous stem cell transplantation for cerebral palsy. Case. Rep. Transplant. 2012; 2012: 825289.
41. Luan Z., Liu W., Qu S. et al. Effects of neural progenitor cell transplantation in children with severe cerebral palsy. Cell. Transplant. 2012. 21(Suppl 1): S91-98.
42. Chen G., Wang Y., Xu Z. et al. Neural stem cell-like cells derived from autologous bone mesenchymal stem cells for the treatment of patients with cerebral palsy. J. Transl. Med. 2013; 11: 21.
43. Jensen A., Hamelmann E. First autologous cell therapy of cerebral palsy caused by hypoxic-ischemic brain damage in a child after cardiac arrest-individual treatment with cord blood. Case. Rep. Transplant. 2013; 2013: 951827.
44. Min K., Song J., Kang J.Y. et al. Umbilical cord blood therapy potentiated with erythropoietin for children with cerebral palsy: a double-blind, randomized, placebo-controlled trial. Stem. Cells. 2013; 31(3): 581-591.
45. Wang L., Ji H., Zhou J. et al. Therapeutic potential of umbilical cord mesenchymal stromal cells transplantation for cerebral palsy: a case report. Case. Rep. Transplant. 2013; 2013: 146347.
46. Ruff C.A., Faulkner S.D., Fehlings M.G. The potential for stem cell therapies to have an impact on cerebral palsy: opportunities and limitations. Dev. Med. Child. Neurol. 2013; 55(8): 689-697.
47. Пичугина Е. Запчасти для человека. Лечение ДЦП: результаты обнадеживают. Московский комсомолец. 2013; 146(107): 17.
48. Bloom R., Przekop A., Sanger T.D. Prolonged electromyogram biofeedback improves upper extremity function in children with cerebral palsy. J. Child. Neurol. 2010; 25(12): 1480-1484.
49. Cheng H.Y., Ju Y.Y., Chen C.L. et al. Managing lower extremity muscle tone and function in children with cerebral palsy via eight-week repetitive passive knee movement intervention. Res. Dev. Disabil. 2013; 34(1): 554-561.
50. Prosser L.A., Curatalo L.A., Alter K.E., Damiano D.L. Acceptability and potential effectiveness of a foot drop stimulator in children and adolescents with cerebral palsy. Dev. Med. Child. Neurol. 2012; 54(11): 1044-1049.